Lit review
by
De Aquino, Joao P. et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.
Findings/Key points
Although there is preliminary evidence that cannabis and its main psychoactive constituent, THC, may alleviate opioid withdrawal, these effects are likely to have a narrow therapeutic window. Further, the potential of cannabinoids to alleviate opioid withdrawal is determined by complex interactions between patient characteristics and pharmacological factors.
Keywords
Withdrawal
Clinical guidance
